Britain Reaches Agreement With GSK, Announces It Will Provide Routine Meningitis B Vaccinations

Associated Press: Britain to offer all infants meningitis B vaccine
“Britain says it will become the first country to offer all babies a vaccine for potentially fatal meningitis B after it reached a price deal with GlaxoSmithKline PLC…” (3/29).

Financial Times: Medics welcome GSK deal to provide meningitis B vaccine
“Patient groups and medics have welcomed an agreement between the government and GlaxoSmithKline to make Britain the first country in the world to provide routine vaccination against meningitis B…” (Ward, 3/29).

Reuters: GSK agrees UK deal for meningitis shot after Novartis stand-off
“GlaxoSmithKline has reached a deal with the British government to supply a new meningitis B vaccine, following a lengthy stand-off over price with the product’s previous owner Novartis…” (Hirschler, 3/29).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.